NorthWest Biotherapeutics Inc (NWBO)

[Doktornolittle]

Maybe you are right there is failure in the wind. But if LP gained any such foresight, it was not certainty of failure, but rather odds of failure. I say that because she went to great lengths to increase odds of approval late in the game by setting up multiple subgroups and forgoing the alpha spend associated with early looks at the data. Both her actions and LL's recent statements point to continued hope of approval for some subgroup(s) which puts the proper valuation for the stock much higher than the present value in my opinion.

Further; even if approved for only a subgroup, if the data suggests that it was only the trial design that got in the way for other subgroups, then the potential for DCVax-L will have been confirmed and credibility will have been regained for NWBO and LP as well.